Arrowhead Pharmaceuticals Announces Global License and …
4 days ago · Upon closing, Arrowhead will receive a $500 million upfront payment and $325 million through the purchase by Sarepta of Arrowhead common stock priced at a 35% …
Arrowhead and Sarepta link for rare genetic disease treatments
3 days ago · Arrowhead Pharmaceuticals has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics to develop treatments for rare genetic diseases. …
Arrowhead Pharmaceuticals Announces Global License and …
4 days ago · PASADENA, Calif., November 26, 2024--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced a global licensing and collaboration agreement with …
Sarepta Therapeutics Announces Global Licensing and …
4 days ago · CAMBRIDGE, Mass., November 26, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today …
Arrowhead to get $825M in Sarepta licensing pact, appoints Sarepta …
4 days ago · Upon closing, Arrowhead will receive a $500M upfront payment and $325M through the purchase by Sarepta of Arrowhead common stock priced at a 35% premium to the 30-day …
Arrowhead Pharmaceuticals Nabs Massive Sarepta Licensing …
4 days ago · Arrowhead Pharmaceuticals inked a licensing deal with Sarepta Therapeutics on Tuesday, and ARWR stock catapulted. The deal focuses on four clinical-stage drugs, three …
Sarepta Inks Global Licensing Deal With Arrowhead, Announces …
4 days ago · During the pre-market hours, Sarepta's stock is climbing 4.23 percent, to $119.50, and Arrowhead's stock is moving up 22.46 percent, to $23.01 on the Nasdaq. SHARE THIS …
Sarepta, Arrowhead Pharmaceuticals partner to advance RNA …
4 days ago · Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases in the …
SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene
3 days ago · Shares of Sarepta Therapeutics SRPT rose nearly 14% on Tuesday after announcing that it has entered into an exclusive global licensing and collaboration agreement …
Arrowhead Pharmaceuticals Announces Global License and
4 days ago · Upon closing, Arrowhead will receive a $500 million upfront payment and $325 million through the purchase by Sarepta of Arrowhead common stock priced at a 35% …
- Some results have been removed